Treatment to Improve Sleep in Caregivers With Insomnia and a Child With Autism

NCT ID: NCT05373537

Last Updated: 2025-06-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-11-05

Study Completion Date

2025-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Autism Spectrum Disorder (ASD) represents one of the most perplexing neurobiological disorders with a prevalence of 1 in 54 children. The lifelong challenging and disruptive behaviors often associated with ASD requires caregivers to change their behavior and modify their environments to provide an ecosystem for optimal outcomes for their child, family and themselves. ASD behaviors can have significant impact on caregivers mental health and family functioning, including the ability to develop and maintain healthy sleep routines. The caregiving population in US has a high prevalence of insomnia; two thirds of caregivers experiencing difficulties falling and/or staying asleep. The prevalence of insomnia in children with ASD is equally high, 60-80% experiencing night waking contributing to poor daytime behavior and disrupted sleep in the caregivers. This pilot RCT will focus on improving caregivers sleep in the context of caring for a child with ASD and insomnia with a multi-disciplinary team. The investigators will compare a home-based tailored CBT for Insomnia (CBT-I) versus a web-based Way to Health CBT-I intervention. This data will support a larger RCT with the Department of Defense funding opportunity through the Congressionally Directed Medical Research Program. This Autism Research Program focuses on improving lives of those living with ASD.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Overall objectives

The investigators propose to compare a home-based tailored CBT-I intervention versus a web-based Way to Health (WTH) platform tailored CBT-I intervention for caregivers with insomnia in the context of caring for a child with ASD and insomnia. This pilot RCT will further the investigators previous work and investigate the feasibility, acceptability, and efficacy of a web based versus home-based CBT-I intervention for both the caregiver with insomnia and the child with ASD and insomnia. The investigators also hope to gain a greater understanding of the relationships between child and caregiver sleep, caregiver psychiatric conditions, child behavior, and maternal self-efficacy. These findings will provide preliminary data for a larger RCT to improve sleep for all family members. The specific aims of this pilot study are:

1. To determine the acceptability and feasibility of a RCT design utilizing a novel, web-based WTH platform versus a home- based CBT-I intervention to improve sleep of a caregiver with insomnia and a child with ASD and insomnia. The investigators plan to evaluate the recruitment, retention, randomization, and training required for this study.
2. To examine the relationship between caregiver self- efficacy, caregiver psychiatric conditions and sleep, and child daytime behaviors and sleep pre and post intervention.
3. To compare the effect of a home- based tailored CBT-I versus web based WTH CBT-I on child and caregiver sleep with a primary endpoint of total sleep time and sleep latency measured with Actigraphy, caregiver mental health scores, and child daytime behaviors.

Primary outcome variable(s)

1. To determine the acceptability and feasibility of a RCT design with the Opinion Survey assessing acceptability with an 8 items rated on a 7- point Likert scale survey This study will be considered feasible if we obtain a 70% completion rate for the repeated measures. Acceptability of the web-based and home based will be determined by parent acceptability survey. This protocol will be considered acceptable to parents if the acceptability score is 70% or greater.
2. To compare the effect of a home- based tailored CBT-I versus web based WTH CBT-I on child and caregiver sleep with a primary endpoint of total sleep time and sleep latency measured with Actigraphy Secondary outcome variable(s) To examine the relationship between caregiver self- efficacy, caregiver psychiatric conditions, child daytime behaviors and sleep parameters pre and post intervention. To examine the mediation effect of caregiver self-efficacy on the relationship between depressive symptoms, caregiver and child sleep, and child symptom severity and behavior, the investigators will use the Baron and Kenny 4-step regression model.71 Independent predictors of depressive symptoms will be tested and adjusted in all analytical steps. Mediation analysis will be performed for all subjects in a pooled sample, followed by a sensitivity analysis to determine the moderating role of child's symptom severity. Conduct a Sobel test to analyze the statistical significance of the mediation effect.

Background Autism Spectrum Disorder (ASD) represents one of the most perplexing neurobiological disorders with a prevalence of 1 in 54 children (1). Substantial heterogeneity exists in the degree of impairment, the collection of behavioral symptoms and the medical conditions associated with ASD. The lifelong challenging and disruptive behaviors often associated with ASD require caregivers to change their behavior and modify their environments to provide an ecosystem for optimal outcomes for their child, family and themselves. However, ASD behaviors can have a significant impact on caregivers mental health and family functioning, including the ability to develop and maintain healthy sleep routines (2). The caregiving population in the U.S. has a high prevalence of insomnia, with two thirds of caregivers experiencing difficulties falling and/or staying asleep. The prevalence of insomnia in children with ASD is equally high, with 60-80% experiencing night waking, contributing to poor daytime child behavior and disrupted caregiver sleep (3, 4). This pilot RCT will focus on improving caregivers sleep in the context of caring for a child with ASD and insomnia with a multi-disciplinary team approach. This pilot data will support a larger RCT with the Department of Defense (DoD) funding opportunity through the Congressionally Directed Medical Research Program. This Autism Research Program focuses on improving lives of those living with ASD.

The investigators recently completed study reveals that 36.6 % of mothers of children with ASD report a psychiatric disorder before and during pregnancy (5). Moreover, 30% of mothers of children with ASD report depression (6-13), revealing the significant vulnerability of this caregiving population. Evidence suggests that insomnia can be a precursor to onset or worsening of psychiatric conditions (14). Maternal depression is associated with lower family functioning, which affects physical, behavioral, and emotional outcomes of children (15-18). Notably, mothers depressive symptoms can interfere with and even blunt the effects of home-based interventions for children with ASD (8). This results in a cycle of poor child outcomes and greater need for intervention (19, 20). Our study of mothers of children with ASD demonstrated that maternal depression and self-efficacy impact child behaviors (21). Therefore, the investigators hypothesize that helping caregivers improve their sleep and their childs sleep, will have a positive impact on mood, cognition, and maternal self-efficacy. Yet, little is known about how family interventions may improve sleep behaviors and mental health in this vulnerable population.

The investigators previously completed RCT examined a home based, modified Cognitive Behavioral Therapy for Insomnia (CBT-I) intervention for children with ASD and insomnia (3, 4). The modified CBT-I is an 8 week intervention developed by the Principal Investigator that includes 1) A one hour education session developed by the Autism Treatment Network, Sleep Tool Kit (Appendix A); 2) Identifying positive evening routines, developing a visual schedule and implementing ecological changes to the bedroom, 3) Introducing a calming module with a choice of 5-12 soothing activities selected by the caregiver/child (Appendix B); and 3) Developing a bedtime protocol pairing irresistible sleepiness with the bedroom (stimulus control). The investigators study, using actigraphy an objective measure of sleep, showed that tailored CBT-I (n=20) decreased wake time in bed by 65 minutes with an effect size=1.05 compared to 19 minutes with an effect size=0.26 in the sleep education only group (n=16). The investigators study suggested that the tailored CBT-I has a larger effect than sleep education on sleep in children with ASD. However, this intervention required frequent and costly home visits by a multi-disciplinary team. In addition, 40% of mothers expressed that they had difficulty implementing CBT-I for their children due to exhaustion and feelings of being overwhelmed related to their own mental health.

To address this gap, the investigators propose to compare a home-based tailored CBT-I intervention versus a web-based Way to Health (WTH) platform tailored CBT-I intervention for caregivers with insomnia in the context of caring for a child with ASD and insomnia. This pilot RCT will further previous work and investigate the feasibility, acceptability, and efficacy of a web based versus home-based CBT-I intervention for both the caregiver with insomnia and the child with ASD and insomnia. The investigators also hope to gain a greater understanding of the relationships between child and caregiver sleep, caregiver psychiatric conditions, child behavior, and maternal self-efficacy. These findings will provide preliminary data for a larger RCT to improve sleep for all family members.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autism Spectrum Disorder Insomnia Chronic Caregiver Burden

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Pilot Randomized control trial Comparing a home-based vs a web-based approach to CBT-Insomnia
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Home-based

home- based CBT-Insomnia intervention

Group Type EXPERIMENTAL

Cognitive behavioral therapy for Insomnia

Intervention Type BEHAVIORAL

Caregiver with insomnia will receive CBT-Insomnia and will be trained to implement CBT-I tailored for their child with Autism Spectrum Disorder and Insomnia

web-based

web-based CBT-Insomnia intervention

Group Type EXPERIMENTAL

Cognitive behavioral therapy for Insomnia

Intervention Type BEHAVIORAL

Caregiver with insomnia will receive CBT-Insomnia and will be trained to implement CBT-I tailored for their child with Autism Spectrum Disorder and Insomnia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cognitive behavioral therapy for Insomnia

Caregiver with insomnia will receive CBT-Insomnia and will be trained to implement CBT-I tailored for their child with Autism Spectrum Disorder and Insomnia

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Caregiver age 18 years or older
* Diagnosis of Insomnia
* Parental/guardian will give permission (informed consent) for child
* Telephone and web Access
* Stable medical and behavioral conditions, with no change in health status in the past three months
* Commitment to maintaining stable medication doses and keeping medication consistent


* Children age 3 to 17 years and one of their parents
* Diagnosis of Autism Spectrum Disorders, confirmed with Autism Diagnostic Observation Schedule and/or DSM-IV criteria.
* Diagnosis of Behavioral Insomnia or Insomnia due to ASD (Insomnia due to internal
* Parental/guardian permission (informed consent) and if appropriate, child assent.
* Telephone and web Access
* Stable medical and behavioral conditions, with no change in health status in the past
* Commitment to maintaining stable medication doses and keeping child's sleep medication consistent

Exclusion Criteria

* Insomnia due to co-occurring medical conditions and/ or sleep disorders such as obstructive sleep apnea (OSA), narcolepsy, restless leg syndrome, severe reflux, nocturnal asthma
* Unstable co-occurring medical conditions such as epilepsy or other neurological disorders, sickle cell anemia, diabetes or severe eczema
* Significant hearing or vision loss
* Known genetic disorders such as Fragile X, 22ql 1.2 Deletion Syndrome, Rett Disorder, Down Syndrome.
* Subjects who, in the opinion of the Investigator, may be non¬ compliant with study schedules or procedures.
Minimum Eligible Age

3 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Children's Hospital of Philadelphia

OTHER

Sponsor Role collaborator

University of Pennsylvania

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Site Status

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

850797

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Optimizing Sleep Health in Nurses
NCT05965609 RECRUITING NA